A recent study has revealed how Epstein-Barr virus (EBV) intensifies ulcerative colitis (UC), a debilitating inflammatory ...

Iron-dependent ferroptosis, a non-apoptotic cell death mechanism, is gaining attention for its role in immune suppression.

BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...

Cesarean section, a surgical procedure for delivering a baby through an incision made in the mother’s abdomen, is generally ...

Astragalus is a powerful adaptogen with immune-boosting, anti-inflammatory, and anti-ageing benefits. Backed by both ...

Johnson & Johnson announced that the FDA has approved TREMFYA, or guselkumab, the first and only IL-23 inhibitor ...

BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025BDC-3042 Phase 1 clinical trial fully enrolled the highest dose cohort with no dose-limiting toxicities (DLTs), resu ...

Horsham: Johnson & Johnson has announced that the Company ahs received approval from the U.S. Food and Drug Administration ...

This review highlights the growing interest in ginsenosides, especially Compound K (CK), as potential anti-aging agents due ...

Fuzheng Jiedu Decoction stands out as a venerable formula with a long history of use. Derived from ancient medical texts and practices, this herbal ...

Skin aging, an inevitable aspect of the aging process, has gained notable attention in research, particularly in the context of finding effective ...